170 likes | 231 Views
Are you looking for RAPS Certification RAC US Exam Dumps? You are at the right place. We provide you real exam questions along with 100% passing assurance and money back guarantee. RAC US Exam Questions compiled by the professional experts. Visit us today and get free RAC US Braindumps PDF file free. Feel free to ask anything about the RAPS RAC US Exam.<br>https://www.exactcert.com/RAC-US-exam-questions.html<br>
E N D
Learn Why RAPS RAC US Dumps is important for your RAC US Exam Preparation?
Looking for RAPS RAC US Exam Dumps?
You are @Right Place Click Here
Did You Know? RAC US Regulatory Affairs Certification is one of The most popular exam now a days.
The name of quality and success. Exactcert provide 100% passing assurance in RAC US Exam. RAC US listed In world most popular certification. https://www.exactcert.com/RAC-US-exam-questions.html
Here are some sample questions for you. Click Here!!! https://www.exactcert.com/RAC-US-exam-questions.html
QuestionNo 1: The Food and Drug Administration Modernization Act (FDAMA) established two types of formal early collaboration meetings. Which of the following is one of those meetings? A. PDP meeting B. Agreement Meeting C. Pre-IDE meeting D. Type A meeting Answer: B https://www.exactcert.com/RAC-US-exam-questions.html
QuestionNo 2: A sponsor intends to submit a Special Protocol Assessment (SPA) request for a clinical trial that will form the primary basis of an efficacy claim in an NDA. Which of the following is TRUE? A. The sponsor should submit the SPA request within 30 days following the start of the trial to expedite FDA feedback B. An SPA provides an opportunity to focus on general drug development issues C. The SPA request will be handled as a request for a Type B meeting D. A sponsor can submit a revised protocol while the agency is reviewing an earlier version of the same protocol Answer: D https://www.exactcert.com/RAC-US-exam-questions.html
QuestionNo 3: Devices that are exempt from premarket notification are: A. All Class I devices B. Some Class I devices C. Most Class I devices and some Class II devices D. All Class I devices and some Class II devices Answer: C https://www.exactcert.com/RAC-US-exam-questions.html
QuestionNo 4: Your company wishes to seek approval of a combination of individually approved anti-hypertensive and anti-diabetic drugs. However, there is no Reference Listed Drug (RLD) for the proposed combination. Which of the following regulatory pathways is most applicable? A. 505(b)(2) B. 510(k) C. 505(b)(1) D. 505(j) Answer: A https://www.exactcert.com/RAC-US-exam-questions.html
QuestionNo 5: The following applies to autologous chondrocytes expanded in vitro for the repair of cartilage defects: A. Regulated under Section 351 of the Public Health Service Act and no premarket approval required B. Regulated under Section 351 of the Public Health Service Act and premarket approval required C. Regulated under Section 361 of the Public Health Service Act and no premarket approval required D. Regulated under Section 361 of the Public Health Service Act and premarket approval required Answer: B https://www.exactcert.com/RAC-US-exam-questions.html
100%Money Back Guarantee
Visit us today and get free demo RAC US Exam Questions file. https://www.exactcert.com/RAC-US-exam-questions.html